125 related articles for article (PubMed ID: 38452690)
1. Arenobufagin inhibits lung metastasis of colorectal cancer by targeting c-MYC/Nrf2 axis.
Wang M; Hu S; Yang J; Yuan L; Han L; Liang F; Zhang F; Zhao H; Liu Y; Gao N
Phytomedicine; 2024 May; 127():155391. PubMed ID: 38452690
[TBL] [Abstract][Full Text] [Related]
2. Arenobufagin, isolated from toad venom, inhibited epithelial-to-mesenchymal transition and suppressed migration and invasion of lung cancer cells via targeting IKKβ/NFκB signal cascade.
Zhao J; Zhang Q; Zou G; Gao G; Yue Q
J Ethnopharmacol; 2020 Mar; 250():112492. PubMed ID: 31866511
[TBL] [Abstract][Full Text] [Related]
3. Arenobufagin inhibits prostate cancer epithelial-mesenchymal transition and metastasis by down-regulating β-catenin.
Chen L; Mai W; Chen M; Hu J; Zhuo Z; Lei X; Deng L; Liu J; Yao N; Huang M; Peng Y; Ye W; Zhang D
Pharmacol Res; 2017 Sep; 123():130-142. PubMed ID: 28712972
[TBL] [Abstract][Full Text] [Related]
4. Disheveled3 enhanced EMT and cancer stem-like cells properties via Wnt/β-catenin/c-Myc/SOX2 pathway in colorectal cancer.
Li Z; Yang Z; Liu W; Zhu W; Yin L; Han Z; Xian Y; Wen J; Tang H; Lin X; Yang Y; Wang J; Zhang K
J Transl Med; 2023 May; 21(1):302. PubMed ID: 37147666
[TBL] [Abstract][Full Text] [Related]
5. BMAL1 promotes colorectal cancer cell migration and invasion through ERK- and JNK-dependent c-Myc expression.
Shan L; Zheng W; Bai B; Hu J; Lv Y; Chen K; Wang X; Pan Y; Huang X; Zhu H; Dai S
Cancer Med; 2023 Feb; 12(4):4472-4485. PubMed ID: 36806631
[TBL] [Abstract][Full Text] [Related]
6. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
[TBL] [Abstract][Full Text] [Related]
7. Forkhead Box S1 mediates epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway to regulate colorectal cancer progression.
Zhang L; Ren CF; Yang Z; Gong LB; Wang C; Feng M; Guan WX
J Transl Med; 2022 Jul; 20(1):327. PubMed ID: 35864528
[TBL] [Abstract][Full Text] [Related]
8. Brusatol suppresses the tumor growth and metastasis of colorectal cancer via upregulating ARRDC4 expression through modulating PI3K/YAP1/TAZ Pathway.
Huang QH; Zhang J; Cho WCS; Huang Y; Yang W; Zuo Z; Xian YF; Lin ZX
Phytomedicine; 2023 Jan; 109():154567. PubMed ID: 36610120
[TBL] [Abstract][Full Text] [Related]
9. Inhibitor of DNA binding 2 knockdown inhibits the growth and liver metastasis of colorectal cancer.
Liu F; Chen S; Yu Y; Huang C; Chen H; Wang L; Zhang W; Wu J; Ye Y
Gene; 2022 Apr; 819():146240. PubMed ID: 35114275
[TBL] [Abstract][Full Text] [Related]
10. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
[TBL] [Abstract][Full Text] [Related]
11.
Cheng C; Huang Z; Zhou R; An H; Cao G; Ye J; Huang C; Wu D
Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G841-G853. PubMed ID: 32146835
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA H19 promotes colorectal cancer metastasis via binding to hnRNPA2B1.
Zhang Y; Huang W; Yuan Y; Li J; Wu J; Yu J; He Y; Wei Z; Zhang C
J Exp Clin Cancer Res; 2020 Jul; 39(1):141. PubMed ID: 32698890
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA‑129 inhibits colorectal cancer cell proliferation, invasion and epithelial‑to‑mesenchymal transition by targeting SOX4.
Chen Z; Zhong T; Zhong J; Tang Y; Ling B; Wang L
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760159
[TBL] [Abstract][Full Text] [Related]
15. Knockdown on aPKC-ι inhibits epithelial-mesenchymal transition, migration and invasion of colorectal cancer cells through Rac1-JNK pathway.
Du GS; Qiu Y; Wang WS; Peng K; Zhang ZC; Li XS; Xiao WD; Yang H
Exp Mol Pathol; 2019 Apr; 107():57-67. PubMed ID: 30465755
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of SLC9A8 Promotes Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer Cells via the IL6-JAK1/STAT3 Signaling Pathway.
Liu W; Geng C; Li X; Li Y; Song S; Wang C
Dig Dis Sci; 2023 May; 68(5):1873-1884. PubMed ID: 36583805
[TBL] [Abstract][Full Text] [Related]
17. LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer.
Sun J; Hu J; Wang G; Yang Z; Zhao C; Zhang X; Wang J
J Exp Clin Cancer Res; 2018 May; 37(1):106. PubMed ID: 29776371
[TBL] [Abstract][Full Text] [Related]
18. Snail/FOXK1/Cyr61 Signaling Axis Regulates the Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.
Huang X; Xiang L; Li Y; Zhao Y; Zhu H; Xiao Y; Liu M; Wu X; Wang Z; Jiang P; Qing H; Zhang Q; Liu G; Zhang W; Li A; Chen Y; Liu S; Wang J
Cell Physiol Biochem; 2018; 47(2):590-603. PubMed ID: 29794466
[TBL] [Abstract][Full Text] [Related]
19. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
Yang Z; Wu D; Chen Y; Min Z; Quan Y
Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
[TBL] [Abstract][Full Text] [Related]
20. MiR-410-3p activates the NF-κB pathway by targeting ZCCHC10 to promote migration, invasion and EMT of colorectal cancer.
Ma ZH; Shi PD; Wan BS
Cytokine; 2021 Apr; 140():155433. PubMed ID: 33517196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
